Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Petros Pharmaceuticals In...

    NASDAQ: PTPI · Real-Time Price · USD
    0.03
    -0.00 (-10.18%)
    At close: Jun 09, 2025, 3:15 PM

    Petros Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 5.11M 5.82M 5.99M 7.81M
    Cost of Revenue
    		 1.21M 1.63M 2.29M 1.6M
    Gross Profit
    		 3.9M 4.19M 3.7M 6.21M
    Operating Income
    		 -17.68M -13.62M -15.85M -18.05M
    Interest Income
    		 371.77K 515.31K 14.19K 368.66K
    Pretax Income
    		 -14.32M -8.16M -20.04M -8.99M
    Net Income
    		 -14.32M -8.16M -27.04M -9.36M
    Selling & General & Admin
    		 8.75M 9.26M 12.21M 15.59M
    Research & Development
    		 2.62M 2.41M 1.74M 1.79M
    Other Expenses
    		 n/a 6.14M 5.6M 6.88M
    Operating Expenses
    		 11.36M 17.81M 19.55M 24.26M
    Interest Expense
    		 560.91K 536.14K 596.02K 368.66K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -15.41M 19.44M 21.84M 25.86M
    Income Tax Expense
    		 26.78B n/a 7M 368.66K
    Shares Outstanding (Basic)
    		 8.03M 1.29M 2.07M 1.09M
    Shares Outstanding (Diluted)
    		 8.03M 2.18M 2.07M 1.09M
    EPS (Basic)
    		 -0.02 -6.35 -9.68 -8.25
    EPS (Diluted)
    		 -0.02 -6.35 -9.68 -8.25
    EBITDA
    		 -10.81M -4.21M -13.73M -1.64M
    EBIT
    		 -13.76M -7.63M -19.44M -8.62M
    Depreciation & Amortization
    		 2.94M 3.42M 5.72M 6.98M

    Add to Watchlist